Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2) [Phase 3]
Phase 3 trial ICONIC-ADVANCE 2 evaluating JNJ-77242113 for moderate-to-severe plaque psoriasis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating JNJ-77242113 for moderate to severe plaque psoriasis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
This clinical trial update describes a regulatory post-marketing surveillance study of Secukinumab (Cosentyx) in Korean patients with hidrad…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis [Phase 3]
An ongoing Phase 3 trial compares CT-P55, a secukinumab biosimilar, with Cosentyx (secukinumab) for moderate to severe plaque psoriasis.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis [EARLY_Phase 1]
An early-phase 1 trial is evaluating the synergistic effects of triamcinolone and vitamin D3 for plaque psoriasis, and the study is currentl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Modifying PEST for Psoriatic Arthritis Screening [NA]
Clinical Trial Update noting modifications to the Psoriasis Epidemiology Screening Tool (PEST) for screening Psoriatic Arthritis, sponsored …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Acupuncture With Chinese Herbal Cream Compare With Acupuncture With Calcipotriol in Plaque Psoriasis. [Phase 2]
A Phase 2 clinical trial comparing acupuncture with a Chinese herbal cream to acupuncture with calcipotriol for plaque psoriasis, currently …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating ICP-488 in adults with moderate to severe plaque psoriasis, assessing efficacy, safety, and pharmacok…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
A real-world study examining whether weight loss influences treatment efficacy in overweight/obese patients with plaque psoriasis; the study…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects [Phase 3]
Phase 3 study evaluating MC2-01 Cream for plaque psoriasis, comparing it with CAL/BDP Gel and vehicle, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]
Open-label Phase 3 trial assessing the safety and efficacy of ponesimod for moderate-to-severe chronic plaque psoriasis; the study is not ye…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]
A Phase 3 trial evaluating concomitant ixekizumab with tirzepatide in adults with plaque psoriasis and obesity is currently active but not r…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital [EARLY_Phase 1]
This clinical trial update describes an early Phase 1 study comparing apremilast versus methotrexate for efficacy in adults with moderate to…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of ICP-332 versus placebo in adults with moderate to severe plaque psoria…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Clinical trial update on secukinumab examining drug survival, effectiveness and tolerability in pediatric patients with moderate-to-severe p…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of IBI112 in adolescent participants with moderate t…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis [Phase 3]
Takeda is conducting a Phase 3 trial comparing Zasocitinib (TAK-279) with deucravacitinib in adults with plaque psoriasis. The study status …
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of D-2570 in adults with moderate to severe plaque psoriasis is currently recrui…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany
Clinical trial update for Deucravacitinib in adults with moderate-to-severe plaque psoriasis in Germany; the study is currently active but n…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
A completed two-year real-world study assessing retention, quality of life, effectiveness and treatment patterns of secukinumab in adults wi…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? [Phase 2]
Phase 2 trial in plaque psoriasis evaluating early intervention with bimekizumab; currently recruiting at CHU Nice.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis [Phase 1]
This clinical trial update indicates that UA026 tablets are being studied in healthy adults and adults with moderate to severe plaque psoria…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis [Phase 3]
This update reports on a Phase 3 clinical trial of apremilast in children with mild to moderate plaque psoriasis. The study is currently act…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity
This Clinical Trial Update describes a Canadian real-world evidence study evaluating brodalumab for plaque psoriasis, aimed at understanding…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 pediatric trial to evaluate the drug levels, efficacy, and safety of deucravacitinib in children with moderate-to-severe plaque psor…